Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Express your “Pharma Pride”, Clearly Communicate Science

Posted on November 23rd, 2015 by

Have you ever tried googling ‘Pharma Industry’? Right after Wikipedia, page after page, you will find various articles referring to ‘Getting High on Fat Profits’, ‘Holding Big Pharma Accountable’. Continue reading “Express your “Pharma Pride”, Clearly Communicate Science” »

David Evans Presents: Catching up with Reaxys PhD Prize winner Dr. Hiroyuki Miyamura

Posted on November 23rd, 2015 by

In a wide ranging interview, we find out what Reaxys PhD Prize Winner Dr. Hiroyuki Miyamura has been up to: Continue reading “David Evans Presents: Catching up with Reaxys PhD Prize winner Dr. Hiroyuki Miyamura” »

Eluding a Post-Antibiotic Era: The Challenge of Designing Novel Antibiotics

Posted on November 13th, 2015 by

As cases of drug-resistant pathogens multiply, the WHO warns of a “post-antibiotic era.” Designing novel antibiotics, however, remains a scientific challenge because achieving therapeutic efficacy requires painstaking testing of compound properties that often conflict. Continue reading “Eluding a Post-Antibiotic Era: The Challenge of Designing Novel Antibiotics” »

Using Reaxys for Lead Optimization: A Case Study

Posted on November 13th, 2015 by

Epigen Biosciences is a start-up pharmaceutical company that collaborates with academic groups to discover innovative drugs for a range of medical conditions, including renal diseases, cancer and CNS disorders. Co-founder Dr. Fabio Tucci met with Elsevier to discuss how Epigen researchers use Reaxys to support their application of advanced hit-to-lead and lead optimization methods. Continue reading “Using Reaxys for Lead Optimization: A Case Study” »

  1. 1
  2. 61
  3. 62
  4. 63